ConductScience.org, home

Paper4087009

Catamenial exacerbation of action myoclonus: successful treatment with acetazolamide.

Goetting MG. J Neurol Neurosurg Psychiatry, 1985. Cited by 4 papers, by iCite.

Cite this record

ConductScience Library. Catamenial exacerbation of action myoclonus: successful treatment with acetazolamide. Papers, record 4087009. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/4087009

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Catamenial exacerbation of action myoclonus: successful treatment with acetazolamide.
PubMed
Journal
J Neurol Neurosurg Psychiatry
PubMed
Year
1985
PubMed
Publication types
Case Reports, Letter
PubMed
Citations, by iCite
4
iCite
Relative citation ratio, by iCite
0.3
iCite
Revised in PubMed
2019-05-01
PubMed

Authors1

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Goetting MGM G

Source PubMed

Download CSV of authors

Topics7

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
AcetazolamideMajor topic
Hypoxia, BrainMajor topic
MyoclonusMajor topic
Adult
Drug Therapy, Combination
Female
Humans

Source PubMed

Download CSV of topics

References7

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
151240Manipulation of brain serotonin in the treatment of myoclonus.Lancet1975https://conductscience.org/library/papers/51240PubMed
2942766Intention myoclonus: successful treatment with clonazepam.Neurology1976https://conductscience.org/library/papers/942766PubMed
31084968Beneficial effects of serotonin precursors in postanoxic action myoclonus.Neurology1976https://conductscience.org/library/papers/1084968PubMed
413928398The syndrome of intention or action myoclonus as a sequel to hypoxic encephalopathy.Brain1963https://conductscience.org/library/papers/13928398PubMed
5351404Post-anoxic action myoclonus: improvement with valproic acid.N Engl J Med1978https://conductscience.org/library/papers/351404PubMed
6229719Posthypoxic action myoclonus: review of the literature and report of two new cases with response to valproate and estrogen.Adv Neurol1979https://conductscience.org/library/papers/229719PubMed
7973554Epileptic seizures in women related to plasma estrogen and progesterone during the menstrual cycle.Acta Neurol Scand1976https://conductscience.org/library/papers/973554PubMed

Download CSV of references

Cited by1

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 4 citations.

PMIDTitleJournalYearIn Papers
15814075Myoclonus.Curr Treat Options Neurol2005https://conductscience.org/library/papers/15814075

Source PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/4087009

GET https://conductscience.org/api/papers/v1/4087009/authors